Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...

DNA microarrays have become synonymous with this kind of study and, in many cases, are the obvious platform to achieve this aim. They have already made important contributions, most notably to ...

After your sample reaches our NABL and CAP-accredited lab, we extract your DNA and perform either full genome sequencing or a ...

Twist Bioscience Corporation , a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Curio Genomics, a pioneer in genomics software, today ...

Research team developed PathActMarker, a software package for pathway activity inference and analysis. It preprocesses gene ...

The process of complex diseases is closely related to the dysregulation of key biological pathways, it is crucial to identify the dysfunctional ...

Dr. Zirvi has been a practicing dermatologist at Summit Health, where he has built a prolific career and earned a reputation ...

ct-DNA, and cf-RNA can be used in any downstream application assay, such as PCR, qPCR, rt-qPCR, methylation-sensitive PCR, Southern Blot analysis, gene expression analysis, microarrays ...

Illumina expects to reach a growth rate in its revenues of 6%-9% CAGR by 2027. See why I think ILMN stock is an appealing ...

A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an ...

Spit in a tube and, for about $100, discover secrets held by your DNA. That was the promise of 23andMe, a direct-to-consumer genetic-testing company. It proved popular—more than 15m customers ...